National Gambling Impact Study Commission. Final report. Washington, DC: Government Printing Office, 1999
National Research Council. Pathological gambling: a critical review. Washington, DC: National Academy Press, 1999
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 2000
Shaffer HJ, Hall MN, Vander Bilt J. Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. Am J Public Health 1999; 89: 1369–76
Stinchfield R. Youth gambling: how big a problem? Psychiatr Ann 2002; 32: 197–202
Weite J, Barnes G, Wieczorek W. Alcohol and gambling pathology among US adults: prevalence, demographic patterns and comorbidity. J Stud Alcohol 2001; 62: 706–12
Bergh C, Kuhlhorn E. Social, psychological and physical consequences of pathological gambling in Sweden. J Gambl Stud 1994; 10: 275–85
Cunningham-Williams RM, Cottier LB, Compton WM, et al. Taking chances: problem gamblers and mental health disorders: results from the St Louis Epidemiologic Catchment Area study. Am J Public Health 1998; 88: 1093–6
Daghestani AN. Impotence associated with compulsive gambling. J Clin Psychiatry 1987; 48: 115–6
Lesieur HR, Blume SB, Zoppa R. Alcoholism, drug abuse and gambling. Alcohol Clin Exp Res 1986; 10: 33–8
Miller MM. Medical approaches to gambling issues (I): the medical condition. Wis Med J 1996; 95: 623–34
Sommers I. Pathological gambling: estimating prevalence and group characteristics. Int J Addict 1988; 23: 477–90
McCormick RA, Russo AM, Ramirez LF, et al. Affective disorders among pathological gamblers seeking treatment. Am J Psychiatry 1984; 141: 215–8
Ladouceur R, Dube D, Bujold A. Prevalence of pathological gamblers and related problems among college students in the Quebec metropolitan area. Can J Psychiatry 1994; 39: 289–93
Petry NM, Kiluk BD. Suicidal ideation and suicide attempts in treatment-seeking pathological gamblers. J Nerv Ment Dis 2002; 190: 462–9
Jacobs DF. Juvenile gambling in North America: an analysis of long term trends and future prospects. J Gambl Stud 2000; 16: 119–52
Westphal JR, Rush JA, Stevens L, et al. Gambling behavior of Louisiana students in grades 6 through 12. Psychiatr Serv 2000; 51: 96–9
Stinchfield R, Winters KC. Gambling and problem gambling among youth. Ann Am Acad Pol Soc Sci 1998; 556: 172–85
Stinchfield R. Gambling and correlates of gambling among Minnesota public school students. J Gambl Stud 2000; 16: 153–73
Volberg R. Gambling and problem gambling among adolescents in New York. Albany (NY): New York Council on Problem Gambling, 1988
Winters KC, Stinchfield R, Botzet A, et al. A prospective study of youth gambling behaviors. Psychol Addict Behav 2002; 16: 3–9
Griffiths M, Sutherland I. Adolescent gambling and drug use. J Community Appl Soc Psychol 1998; 8: 423–7
Stinchfield R, Cassuto N, Winters K, et al. Prevalence of gambling among Minnesota public school students in 1992 and 1995. J Gambl Stud 1997; 13: 25–48
Vitaro F, Ferland F, Jacques C, et al. Gambling, substance use, and impulsivity during adolescence. Psychol Addict Behav 1998; 12: 185–94
Petry NM, Tawfik Z. Comparison of problem-gambling and non-problem-gambling youths seeking treatment for marijuana abuse. J Am Acad Child Adolesc Psychiatry 2001; 40: 1324–31
Barnes GM, Weite JW, Hoffman JH, et al. Gambling and alcohol use among youth: influences of demographic, socialization, and individual factors. Addict Behav 1999; 24: 749–67
Gupta R, Derevensky JL. Familial and social influences on juvenile gambling. J Gambl Stud 1997; 13: 179–92
Browne BA, Brown DJ. Predictors of lottery gambling among American college students. J Soc Psychol 1994; 134: 339–47
Lesieur HR, Klein R. Pathological gambling among high school students. Addict Behav 1987; 12: 129–35
Vitaro F, Arseneault L, Tremblay RE. Dispositional predictors of problem gambling in male adolescents. Am J Psychiatry 1997; 154: 1769–70
Vitaro F, Arseneault L, Tremblay RE. Impulsivity predicts problem gambling in low SES adolescent males. Addiction 1999; 94: 565–75
Winters KC, Stinchfield R, Fulkerson J. Toward the development of an adolescent gambling problem severity scale. J Gambl Stud 1993; 9: 371–86
Lesieur HR, Blume SB. The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry 1987; 144: 1184–8
Ferris J, Wynne H, Single E. Measuring problem gambling in Canada: final report-phase I. Ottawa (ON): Inter-Provincial Task Force on Problem Gambling, 1999
Fisher S. Measuring pathological gambling in children: the case of fruit machines in the UK. J Gambl Stud 1992; 8: 263–85
Derevensky JL, Gupta R. Prevalence estimates of adolescent gambling: a comparison of the SOGS-RA, DSM-IV-J, and the GA 20 questions. J Gambl Stud 2000; 16: 227–51
Fisher S. Developing the DSM-IV criteria to identify adolescent problem gambling in non-clinical populations. J Gambl Stud 2000; 16: 253–73
Shaffer HJ, LaBrie R, Scanlan KM, et al. Pathological gambling among adolescents: Massachusetts Gambling Screen (MAGS). J Gambl Stud 1994; 10: 339–62
Gamblers Anonymous International Service Office. 20 questions [online]. Available from URL: http://www.gamblersanonymous.org/20questions.html/ [Accessed 2003 Feb 27]
Petry NM, Armentano C. Prevalence, assessment and treatment of pathological gambling: a review. Psychiatr Serv 1999; 50: 1021–7
Stewart RM, Brown RIF. An outcome study of Gamblers Anonymous. Br J Psychiatry 1988; 152: 284–8
Lesieur HR, Blume SB. Evaluation of patients treated for pathological gambling in a combined alcohol, substance abuse, and pathological gambling treatment unit using the addiction severity index. Br J Addict 1991; 86: 1017–28
Russo AM, Taber JI, McCormick RA, et al. An outcome study of an inpatient treatment program for pathological gamblers. Hosp Community Psychiatry 1984; 35: 823–7
Taber JI, McCormick RA, Ramirez LF. The prevalence and impact of major life Stressors among pathological gamblers. Int J Addict 1987; 22: 71–9
Petry NM. Patterns and correlates of Gamblers Anonymous attendance in pathological gamblers seeking professional treatment. Addict Behav 2003; 28: 1049–62
Gaboury A, Ladouceur R. Erroneous perceptions and gambling. J Soc Behav Pers 1989; 4: 411–20
Sylvain C, Ladouceur R, Boisvert JM. Cognitive and behavioral treatment of pathological gambling: a controlled study. J Consult Clin Psychol 1997; 65: 727–32
Ladouceur R, Sylvain C, Boutin C, et al. Cognitive treatment of pathological gambling. J Nerv Ment Dis 2001; 189: 774–80
Ladouceur R, Boisvert JM, Dumont J. Cognitive-behavioral treatment for adolescent pathological gamblers. Behav Modif 1994; 18: 230–42
Gupta R, Derevensky JL. Adolescents with gambling problems: from research to treatment. J Gambl Stud 2000; 16: 315–42
Miller WR, Brown JM, Simpson TL, et al. A methodological analysis of the alcohol treatment outcome literature. In: Hester RK, Miller WR, editors. Handbook of alcoholism treatment approaches. Boston (MA): Allyn & Bacon, 1995: 12–44
Hodgins DC, Currie SR, el-Guebaly N. Motivational enhancement and self-help treatments for problem gambling. J Consult Clin Psychol 2001; 69: 50–7
Sampl S, Kadden R. Motivational enhancement therapy and cognitive behavioral therapy for adolescent cannabis users: 5 sessions. Cannabis Youth Treatment (CYT) Series. Vol. 1. Rockville (MD): Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, 2001
Hollander E, Frenkel M, DeCaria C, et al. Treatment of pathological gambling with clomipramine. Am J Psychiatry 1992; 149: 710–1
Sallee FR, Vrindavanam NS, Deas-Nesmith D, et al. Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial. Am J Psychiatry 1997; 154: 668–7
Remington G, Sloman L, Konstantareas M, et al. Clomipramine versus haloperidol in the treatment of autistic disorder: a double-blind, placebo-controlled, crossover study. J Clin Psychopharmacol 2001; 21: 440–4
Figueroa Y, Rosenberg DR, Birmaher B, et al. Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents. J Child Adolesc Psychopharmacol 1998; 8: 61–7
Hollander E, DeCaria C, Mari E, et al. Short-term single-blind fluvoxamine treatment of pathological gambling. Am J Psychiatry 1998; 155: 1781–3
Hollander E, DeCaria CM, Finkell JN, et al. A randomized double-blind fluvox-amine/placebo crossover trial in pathologic gambling. Biol Psychiatry 2000; 47: 813–7
Blanco C, Petkova E, Ibanez A, et al. A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann Clin Psychiatry 2002; 14: 9–15
Cheer SM, Figgitt DP. Spotlight on fluvoxamine in anxiety disorders in children and adolescents. CNS Drugs 2002; 16: 139–44
Strauss WL, Unis AS, Cowan C, et al. Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders. Am J Psychiatry 2002; 159: 755–60
Zimmerman M, Breen RB, Posternak MA. An open-label study of citalopram in the treatment of pathological gambling. J Clin Psychiatry 2002; 63: 44–8
Armenteros JL, Lewis JE. Citalopram treatment for impulsive aggression in children and adolescents: an open pilot study. J Am Acad Child Adolesc Psychiatry 2002; 41: 522–9
Seedat S, Stein DJ, Ziervogel C, et al. Comparison of response to a selective serotonin reuptake inhibitor in children, adolescents, and adults with post-traumatic stress disorder. J Child Adolesc Psychopharmacol 2002; 12: 37–46
Thomsen PH, Ebbesen C, Persson C. Long-term experience with citalopram in the treatment of adolescent OCD. J Am Acad Child Adolesc Psychiatry 2001; 40: 895–902
Bostic JQ, Prince J, Brown K, et al. A retrospective study of citalopram in adolescents with depression. J Child Adolesc Psychopharmacol 2001; 11: 159–66
Kim SW, Grant JE, Adson DE, et al. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry 2002; 63: 501–7
Keller MB, Ryan ND, Strober M, et al. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2001; 40: 762–72
Rosenberg DR, Stewart CM, Fitzgerald KD, et al. Paroxetine open-label treatment of pediatric outpatients with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1999; 38: 1180–5
de la Gandara JJ. Fluoxetine: open-trial in pathological gambling. 152nd Annual Meeting of the American Psychiatric Association; 1999 May 16–21; Washington, DC
Emslie GJ, Rush AJ, Weinberg WA, et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997; 54: 1031–7
Geller DA, Hoog SL, Heiligenstein JH, et al. Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial. J Am Acad Child Adolesc Psychiatry 2001; 40: 773–9
Black B, Uhde TW. Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 1994; 33: 1000–6
Grant JE, Kim SW. Pharmacotherapy of pathological gambling. Psychiatr Ann 2002; 32: 186–91
Kim SW, Grant JE, Adson DE, et al. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 2001; 49: 914–21
Crockford DN, el-Guebaly N. Naltrexone in the treatment of pathological gambling and alcohol dependence [letter]. Can J Psychiatry 1998; 43: 86
Campbell M, Anderson LT, Small AM, et al. Naltrexone in autistic children: a double-blind and placebo-controlled study. Psychopharmacol Bull 1990; 26: 130–5
Wold M, Kaminer Y. Naltrexone for alcohol abuse. J Am Acad Child Adolesc Psychiatry 1997; 36: 6–7
Chabane N, Leboyer M, Mouren-Simeoni MC. Opiate antagonists in children and adolescents. Eur Child Adolesc Psychiatry 2000; 9Suppl. 1: 144–50
Moskowitz JA. Lithium and lady luck: use of lithium carbonate in compulsive gambling. NY State J Med 1980; 80: 785–8
Pallanti S, Quercioli L, Sood E, et al. Lithium and valproate treatment of pathological gambling: a randomized single-blind study. J Clin Psychiatry 2002; 63: 559–64
Haller R, Hinterhuber H. Treatment of pathological gambling with carbamazepine [letter]. Pharmacopsychiatry 1994; 27: 129
Kowatch RA, Suppes T, Carmody TJ, et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2000; 39: 713–20
Donovan SJ, Stewart JW, Nunes EV, et al. Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design. Am J Psychiatry 2000; 157: 818–20
Ryan ND, Bhatara VS, Perel JM. Mood stabilizers in children and adolescents. J Am Acad Child Adolesc Psychiatry 1999; 38: 529–36
McElroy SL, Pope HG, Keck PE, et al. Are impulse-control disorders related to bipolar disorder? Compr Psychiatry 1996; 37: 229–40
Hardoon K, Derevensky J, Gupta R. Empirical measures vs perceived gambling severity: why adolescents don’t present themselves for treatment. Addict Behav 2003; 28: 933–46
Crockford DN, el-Guebaly N. Psychiatric comorbidity in pathological gambling: a critical review. Can J Psychiatry 1998; 43: 43–50
Kim SW, Grant JE, Grosz RL. Pathological gambling: current status and new treatments. Minn Med 2002; 85: 48–52
Grant JE, Kim SW. Effectiveness of pharmacotherapy for pathological gambling: a chart review. Ann Clin Psychiatry 2002; 14: 155–61
Petry NM. How treatments for pathological gambling can be informed by treatments for substance use disorders. Exp Clin Psychopharmacol 2002; 10: 184–92
American Gaming Association. Responsible gaming resource guide. 2nd ed. Washington, DC: American Gaming Association, 1998
Gaboury A, Ladouceur R. Evaluation of a prevention program for pathological gambling among adolescents. J Prim Prev 1993; 14: 21–8
Dickson LM, Derevensky JL, Gupta R. The prevention of gambling problems in youth: a conceptual framework. J Gambl Stud 2002; 18: 97–159